Elderly Patients: Single Agent vs. Doublet Chemotherapy

preview_player
Показать описание
Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, discusses the use of single agent vs. doublet chemotherapy in elderly patients.

  1. GRACE - Global Resource for Advancing Cancer Education
  2. GRACE
  3. cancerGRACE
  4. GRACEcast
  5. GCVL
  6. GCVL-Lung
Рекомендации по теме
Elderly Patients: Single 0:06:35

Elderly Patients: Single Agent vs. Doublet Chemotherapy

Elderly Patients: Selecting 0:06:54

Elderly Patients: Selecting Appropriate Systemic Treatment Agents

IPSOS: 1L atezolizumab 0:05:36

IPSOS: 1L atezolizumab vs single-agent chemotherapy in patients with platinum-ineligible NSCLC

Debate - Alkylating 0:28:47

Debate - Alkylating agents as part of frontline therapy in the elderly | Yong vs Facon

Novel approaches to 0:03:29

Novel approaches to treating AML in elderly patients

22 1 subDoublet 0:01:00

22 1 subDoublet versus single agent ruxolitinib in myelofibrosis

Dr. Tracey Evans 0:00:43

Dr. Tracey Evans on Chemotherapy for the Elderly Patient

What treatment challenges 0:02:24

What treatment challenges do elderly patients face in AML?

10 Reading Terms 0:23:57

10 Reading Terms Every Caregiver Should Know | IMO Top Acronyms Used by Medical and Care Providers

What are the 0:04:59

What are the leading clinical trials in older patients with AML?

Impact Of Premedication 0:12:27

Impact Of Premedication On The Elderly Patient

Novel Agents in 0:20:21

Novel Agents in Elderly CLL Patients: Should the Approach be Different?

Targeted agents in 0:01:46

Targeted agents in acute myeloid leukemia in elderly patients

GU cancer: treating 0:01:13

GU cancer: treating elderly patients

Dr. Jahanzeb on 0:01:49

Dr. Jahanzeb on Immunotherapy in Elderly Patients With NSCLC

Single agent or 0:01:31

Single agent or combination therapy for NSCLC?

The complications of 0:02:20

The complications of treating elderly patients with AML

Underrepresentation of elderly 0:03:47

Underrepresentation of elderly patients with CLL in clinical trials

Elderly patients with 0:02:52

Elderly patients with HL: unmet needs and promising strategies

Optimise the Use 1:02:28

Optimise the Use of Drugs for Elderly Patients | Prof Sarah Hilmer

Acute Myeloid Leukemia: 0:17:34

Acute Myeloid Leukemia: Debate on Standard of Care for Patients ≥ 60 Years

The use of 0:03:21

The use of immunotherapy and targeted agents to treat elderly lung cancer patients

Glasdegib plus low-dose 0:02:44

Glasdegib plus low-dose cytarabine for elderly AML patients who have failed HMAs

Study of Single-Agent 0:57:06

Study of Single-Agent Lenvatinib with Refractory/Relapsed Solid Malignancies & YA with Osteosarc...